trending Market Intelligence /marketintelligence/en/news-insights/trending/iSnAr740yWuNW46TycDF4g2 content esgSubNav
In This List

2 FluoroPharma directors resign

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


2 FluoroPharma directors resign

Peter Conti and Johan Spoor agreed to resign as directors of FluoroPharma Medical Inc., effective Jan. 1, 2017.

The resignations are not due to any disagreements on any matter relating to the company's operations, policies and practices.